Multimodal molecular imaging in drug discovery and development.

Area of Science:

• Biomedical imaging
• Drug discovery and development
• Translational medicine

Background:

• Multimodal imaging integrates diverse techniques for comprehensive anatomical, functional, and molecular data.
• Imaging technologies are crucial for understanding disease mechanisms and identifying therapeutic targets.

Purpose of the Study:

• To review the application of various imaging techniques across drug discovery and development phases.
• To highlight innovations and future potential of imaging in pharmaceuticals.
• To emphasize the role of artificial intelligence (AI) and radiomics in advancing imaging technologies.

Main Methods:

• Review of current imaging modalities used in preclinical and clinical drug development.
• Analysis of AI and radiomics applications in image analysis and interpretation.
• Discussion of strengths and limitations of different imaging approaches.

Main Results:

• Multimodal imaging offers synergistic information, accelerating the identification and validation of drug candidates.
• AI and radiomics significantly enhance the predictive power and efficiency of imaging in drug development.
• Imaging plays a vital role from target identification to treatment response assessment.

Conclusions:

• Integrated imaging strategies, powered by AI and radiomics, are transforming drug discovery and development.
• The future of pharmaceutical research relies on advanced imaging for precise and efficient therapeutic innovation.
• Harnessing multimodal imaging capabilities is key to overcoming challenges in bringing new medicines to patients.